| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.93B | 131.66B | 133.52B | 113.72B | 107.09B | 101.78B |
| Gross Profit | 25.36B | 23.55B | 22.88B | 22.44B | 19.83B | 18.30B |
| EBITDA | 20.61B | 18.75B | 17.89B | 17.56B | 15.86B | 14.20B |
| Net Income | 14.17B | 12.82B | 12.29B | 12.01B | 10.80B | 9.63B |
Balance Sheet | ||||||
| Total Assets | 167.97B | 172.95B | 168.15B | 156.03B | 140.18B | 126.55B |
| Cash, Cash Equivalents and Short-Term Investments | 72.91B | 82.65B | 84.17B | 74.60B | 65.17B | 62.66B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 47.00M |
| Total Liabilities | 44.78B | 50.64B | 55.05B | 53.59B | 48.56B | 44.65B |
| Stockholders Equity | 123.19B | 122.31B | 113.09B | 102.43B | 91.61B | 81.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.29B | 11.50B | 10.46B | 3.69B | 6.98B |
| Operating Cash Flow | 0.00 | 2.65B | 11.70B | 10.59B | 3.77B | 7.00B |
| Investing Cash Flow | 0.00 | -34.43B | -247.00M | 123.00M | -123.00M | -403.00M |
| Financing Cash Flow | 0.00 | -3.74B | -1.88B | -1.28B | -1.13B | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥146.65B | 9.06 | ― | 3.22% | 12.23% | 43.29% | |
79 Outperform | ¥118.20B | 10.36 | ― | 3.81% | 0.82% | 30.84% | |
76 Outperform | ¥95.50B | 13.41 | ― | 4.38% | -0.84% | -1.80% | |
69 Neutral | ¥115.46B | 11.04 | ― | 2.81% | -3.99% | 13.29% | |
68 Neutral | ¥127.39B | 11.19 | ― | 2.14% | 4.81% | -1.16% | |
64 Neutral | ¥116.88B | 13.33 | ― | 2.13% | 7.22% | 21.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |